Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Lys-Pro)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003778 AN006205 Human to mouse microbiota transfer model demonstrates disease-modifying effects of the short-chain fatty acid biotherapy modified microbiota Feces Mouse Diabetes University of Queensland LC-MS
ST003768 AN006185 The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass Leaf Grass Hunan Agricultural University LC-MS
ST003768 AN006185 The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass Roots Grass Hunan Agricultural University LC-MS
ST003565 AN005857 Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST003521 AN005782 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University LC-MS
ST003521 AN005783 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University LC-MS
ST003213 AN005269 The central role of creatine and polyamines in fetal growth restriction Placenta Human Placenta disease University of Udine LC-MS
ST003179 AN005221 Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST003160 AN005184 New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST003144 AN005159 On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity Blood Plasmodium falciparum Malaria Monash University LC-MS
ST003053 AN005006 Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics Bacterial cells Staphylococcus aureus Bacterial infection Monash University LC-MS
ST003036 AN004977 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 Bacterial cells Pseudomonas aeruginosa Bacterial infection Monash Institute of Pharmaceutical Sciences LC-MS
ST003024 AN004958 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 Bacterial cells Pseudomonas aeruginosa Monash Institute of Pharmaceutical Sciences LC-MS
ST003002 AN004931 The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench (2) Feces Human Sarcopenia Chinese University of Hong Kong GC/LC-MS
ST002977 AN004887 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002977 AN004889 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002926 AN004798 Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides fragilis Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides thetaiotaomicron Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides uniformis Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Blautia producta Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium clostridioforme Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hathewayi Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hylemonae Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium scindens Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium symbiosum Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecalis Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecium Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus hirae Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Escherichia fergusonii Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Flavonifractor plautii Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Parabacteroides distasonis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides fragilis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides thetaiotaomicron Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides uniformis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Blautia producta Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium clostridioforme Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hathewayi Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hylemonae Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium scindens Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium symbiosum Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecalis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecium Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus hirae Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Escherichia fergusonii Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Flavonifractor plautii Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Parabacteroides distasonis Stanford University LC-MS
ST002792 AN004542 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002787 AN004534 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology LC-MS
ST002775 AN004517 Zebrafish Retina Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami LC-MS
ST002761 AN004487 Metabolic responses of normal rat kidneys to a high salt intake (Urine) Urine Rat Medical College of Wisconsin LC-MS
ST002747 AN004454 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Human CZ Biohub LC-MS
ST002747 AN004454 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Rickettsia parkeri CZ Biohub LC-MS
ST002512 AN004136 Gnotobiotic mice: Metabolites in intestinal contents of germ-free mice colonized with strains of gut bacterium Eggerthella lenta Intestine Mouse University of California, San Francisco LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002472 AN004037 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Veillonella parvula cell and media profiling Bacterial cells Veillonella parvula Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002471 AN004033 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002427 AN003950 Dansylated Human Plasma at Known Light-Heavy Mixing Ratios Blood Human University of North Carolina Greensboro LC-MS
ST002407 AN003924 Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract Intestine Human University of California, Davis LC-MS
ST002309 AN003771 Targeting malaria parasites with novel derivatives of azithromycin Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002247 AN003670 Microbiota and Health Study (Dhaka, Bangladesh) Feces Human Broad Institute of MIT and Harvard LC-MS
ST002184 AN003577 Metabolic effect of the loss of mitochondrial-specific aspartyl-tRNA synthetase Das2 on mouse intestinal epithelial cells Intestine Mouse CECAD Research Center LC-MS
ST002152 AN003523 Metabolomics analysis of mouse liver with or without SIRT5 deficiency Liver Mouse North Carolina State University LC-MS
ST002119 AN003467 Metabolomics analysis of zebrafish response to CID661578 treatment Larvae Zebrafish Diabetes North Carolina State University LC-MS
ST002108 AN003448 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002107 AN003446 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002106 AN003444 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST002028 AN003298 Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/HILIC) Feces Human University of California, Davis LC-MS
ST001841 AN002984 Metabolomics of lung microdissections reveals region- and sex-specific metabolic effects of acute naphthalene exposure in mice (part II) Liver Mouse Oxidative stress University of California, Davis GC-MS
ST001794 AN002911 Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples Jejunum Human University of California, Davis LC-MS
ST001324 AN002202 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Hepatopancreas Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences LC-MS
ST001315 AN002189 Retargeting azithromycin-like compounds as antimalarials with dual modality Blood Plasmodium falciparum Malaria Monash University LC-MS
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001175 AN001950 Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST001033 AN001694 Determination of mode of action of anti-malalrial drugs using untargeted metabolomics Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST000546 AN000832 Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium Cells Plasmodium falciparum Malaria Monash University LC-MS
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash University LC-MS
ST000414 AN000655 Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences LC-MS
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences LC-MS
  logo